⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9470785 | 0.81 | POLB (0.54) | — | |
| SCHEMBL9729953 | 0.81 | — | — | |
| SCHEMBL9728949 | 0.81 | — | — | |
| SCHEMBL9470261 | 0.75 | GLS (0.49) | — | |
| SCHEMBL9471443 | 0.75 | GLS (0.49) | — | |
| SCHEMBL9469960 | 0.74 | — | — | |
| SCHEMBL9470780 | 0.74 | — | — | |
| SCHEMBL9559085 | 0.74 | P2RY1 (0.58) | — | |
| SCHEMBL9730043 | 0.73 | — | — | |
| SCHEMBL9470525 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5162360-A | Treating hypercholesterolemia and atherosclerosis; ACAT acyl-coenzyme A:-cholesterol acyltransferase | WARNER-LAMBERT COMPANY (US) | 1992-11-10 | — | — | US | claimed |
| US-5162360-A | Treating hypercholesterolemia and atherosclerosis; ACAT acyl-coenzyme A:-cholesterol acyltransferase | WARNER-LAMBERT COMPANY (US) | 1992-11-10 | — | — | US | disclosed |